Efficacy Of Oral Isotretinoin With Levocetirizine Vs Oral Isotretinoin Monotherapy In Acne Vulgaris: A Randomised Controlled Trial
试验速览
- 阶段
- 2/3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- To determine whether Isotretinoin with levocetirizine is more effective than isotretinoin alone for treating acne vulgaris.
研究概览
简要总结
This randomized, assessor-blinded pilot trial compares oral isotretinoin plus levocetirizine versus isotretinoin alone in 60 adults with moderate to severe acne vulgaris to determine whether combination therapy offers superior clinical outcomes. Acne is a multifactorial inflammatory condition, and while isotretinoin is the gold standard, antihistamines may enhance its efficacy by reducing inflammation, itch, squalene and sebum levels, and scratching-related excoriation. Participants are randomised into two groups, assessed at baseline and then every four weeks for 12 weeks using GAGS, VAS, DLQI, and adverse event monitoring. The study hypothesizes that adding levocetirizine will lead to greater reductions in acne severity and improved quality of life. Statistical analysis will use t-tests, Mann-Whitney tests, and correlation methods through SPSS v26.0 to compare outcomes between groups. The expected conclusion is that the combination regimen will outperform isotretinoin monotherapy in both efficacy and symptomatic relief.
研究设计
- 研究类型
- Interventional
- 分配方式
- Coin toss, Lottery, toss of dice, shuffling cards etc
- 盲法
- Outcome Assessor Blinded
入排标准
- 年龄范围
- 18.00 Year(s) 至 45.00 Year(s)(—)
- 性别
- All
入选标准
- •Patients aged more than 18 years with a diagnosis of moderate to severe acne vulgaris
- •Patients available for regular follow-up visits during the study period.
排除标准
- •1.Patients with a known allergy or intolerance to isotretinoin.
- •2.Patients with deranged LFT and Lipid Profile.
- •3.Patients planning for pregnancy, Pregnant or lactating women.
结局指标
主要结局
To determine whether Isotretinoin with levocetirizine is more effective than isotretinoin alone for treating acne vulgaris.
时间窗: 12 weeks
次要结局
- To assess the impact of combination therapy on a patient’s overall quality of life(12 weeeks)
研究者
Dr Debasmita Behera
Kalinga institute of medical sciences
